Publication | Closed Access

Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer

Her-2-overexpressing Breast CancerNanomedicineDrug TargetingOncologyEngineeringPolymer-drug ConjugateMedicineBreast CancerTumor TargetingNano-drug DeliveryBiomedical EngineeringPharmacology